An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts
- PMID: 6765248
An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts
Abstract
3LL tumor cells inoculated intra footpad grow locally both in syngeneic and in allogeneic recipients. Yet, spontaneous lung metastases appear only in syngeneic animals or in mice which share with the tumor strain of origin both the D-end of the H-2b haplotype and the genetic background. The lack of lung metastases in allogeneic recipients is not due to tissue restrictions for tumor growth, since intravenous injections of tumor cells resulted in local primary lung tumors. The growth rate of primary intra footpad tumors or pulmonary tumors in syngeneic mice is similar to that in congenic resistant recombinant mice. From a local intra footpad tumor in BALB/c mice, 3LL cells migrate out and reach the lungs but are arrested there, since grafts of lungs from such mice onto (BALB/c X C57BL/6)F1 resulted in tumor growth. Since spontaneous metastases developed in chimeric (C3HeB X C57BL/6)F1----C3HeB mice, it appeared that immunogenetic restrictions prevent the growth of spontaneous 3LL metastases in allogeneic recipients. Further support for the notion of allograft rejection of lung metastases derived from experiments demonstrating the generation of metastases in nu/nu ICR mice but not in nu/+ heterozygous ICR animals. It thus appeared that the local allograft of the 3LL tumor elicits a reaction which prevents the growth of its metastases. This was further supported in experiments in which intravenous inoculation of 3LL cells to allogeneic recipients from which the local tumor was removed did not produce lung tumors.
Similar articles
-
Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.J Natl Cancer Inst. 1981 May;66(5):919-26. J Natl Cancer Inst. 1981. PMID: 6939934
-
Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.J Natl Cancer Inst. 1980 Dec;65(6):1257-64. J Natl Cancer Inst. 1980. PMID: 6933271
-
Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.J Supramol Struct. 1979;12(3):385-402. doi: 10.1002/jss.400120309. J Supramol Struct. 1979. PMID: 94933
-
Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers.Exp Clin Immunogenet. 1984;1(3):170-4. Exp Clin Immunogenet. 1984. PMID: 6401004
-
Somatic hybridization and oncogenesis; (Mechanism of formation of malignant tumors and metastases by the action of antilymphocytic serum).Sov J Dev Biol. 1975 May;5(3):201-19. Sov J Dev Biol. 1975. PMID: 164699 Review.
Cited by
-
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity.Clin Exp Metastasis. 1987 Jan-Mar;5(1):43-56. doi: 10.1007/BF00116625. Clin Exp Metastasis. 1987. PMID: 3829496
-
Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model.J Neurooncol. 2013 Jan;111(2):133-43. doi: 10.1007/s11060-012-1006-1. Epub 2012 Nov 27. J Neurooncol. 2013. PMID: 23184143 Free PMC article.
-
Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenic mice.Cancer Immunol Immunother. 1991;32(6):373-81. doi: 10.1007/BF01741332. Cancer Immunol Immunother. 1991. PMID: 1826094 Free PMC article.
-
Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma.J Exp Med. 2003 Nov 17;198(10):1475-85. doi: 10.1084/jem.20030202. Epub 2003 Nov 10. J Exp Med. 2003. PMID: 14610043 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials